|
|
||||||||




* Laboratory of Experimental Internal Medicine,
Department of Pathology and
Department of Internal Medicine, Division of Infectious Diseases, Tropical Medicine, and AIDS, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands;
Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037; and
¶ Department of Host Defense, Research Institute for Microbial Diseases, Osaka University, Japan
TLRs are important for the recognition of conserved motifs expressed by invading bacteria. TLR4 is the signaling receptor for LPS, the major proinflammatory component of the Gram-negative cell wall, whereas CD14 serves as the ligand-binding part of the LPS receptor complex. Triggering of TLR4 results in the activation of two distinct intracellular pathways, one that relies on the common TLR adaptor MyD88 and one that is mediated by Toll/IL-1R domain-containing adaptor-inducing IFN-
(TRIF). Nontypeable Haemophilus influenzae (NTHi) is a common Gram-negative respiratory pathogen that expresses both TLR4 (LPS and lipooligosaccharide) and TLR2 (lipoproteins) ligands. To determine the roles of CD14, TLR4, and TLR2 during NTHi pneumonia, the following studies were performed: 1) Alveolar macrophages from CD14 and TLR4 knockout (KO) mice were virtually unresponsive to NTHi in vitro, whereas TLR2 KO macrophages displayed a reduced NTHi responsiveness. 2) After intranasal infection with NTHi, CD14 and TLR4 KO mice showed an attenuated early inflammatory response in their lungs, which was associated with a strongly reduced clearance of NTHi from the respiratory tract; in contrast, in TLR2 KO mice, lung inflammation was unchanged, and the number of NTHi CFU was only modestly increased at the end of the 10-day observation period. 3) MyD88 KO, but not TRIF mutant mice showed an increased bacterial load in their lungs upon infection with NTHi. These data suggest that the MyD88-dependent pathway of TLR4 is important for an effective innate immune response to respiratory tract infection caused by NTHi.
This article has been cited by other articles:
![]() |
B. Pang, D. Winn, R. Johnson, W. Hong, S. West-Barnette, N. Kock, and W. E. Swords Lipooligosaccharides Containing Phosphorylcholine Delay Pulmonary Clearance of Nontypeable Haemophilus influenzae Infect. Immun., May 1, 2008; 76(5): 2037 - 2043. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Leendertse, R. J. L. Willems, I. A. J. Giebelen, P. S. van den Pangaart, W. J. Wiersinga, A. F. de Vos, S. Florquin, M. J. M. Bonten, and T. van der Poll TLR2-Dependent MyD88 Signaling Contributes to Early Host Defense in Murine Enterococcus faecium Peritonitis J. Immunol., April 1, 2008; 180(7): 4865 - 4874. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. D. van Zoelen, S. Florquin, J. C. M. Meijers, R. de Beer, A. F. de Vos, O. J. de Boer, and T. van der Poll Platelet-Activating Factor Receptor Contributes to Host Defense against Pseudomonas aeruginosa Pneumonia but Is Not Essential for the Accompanying Inflammatory and Procoagulant Response J. Immunol., March 1, 2008; 180(5): 3357 - 3365. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. McAleer, D. J. Zammit, L. Lefrancois, R. J. Rossi, and A. T. Vella The Lipopolysaccharide Adjuvant Effect on T Cells Relies on Nonoverlapping Contributions from the MyD88 Pathway and CD11c+ Cells J. Immunol., November 15, 2007; 179(10): 6524 - 6535. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Wieland, S. Florquin, and T. van der Poll Interleukin 18 Participates in the Early Inflammatory Response and Bacterial Clearance during Pneumonia Caused by Nontypeable Haemophilus influenzae Infect. Immun., October 1, 2007; 75(10): 5068 - 5072. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Moon, J.-I. Woo, H.-Y. Lee, R. Park, J. Shimada, H. Pan, R. Gellibolian, and D. J. Lim Toll-Like Receptor 2-Dependent NF-{kappa}B Activation Is Involved in Nontypeable Haemophilus influenzae-Induced Monocyte Chemotactic Protein 1 Up-Regulation in the Spiral Ligament Fibrocytes of the Inner Ear Infect. Immun., July 1, 2007; 75(7): 3361 - 3372. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Dessing, K. F. van der Sluijs, S. Florquin, S. Akira, and T. van der Poll Toll-Like Receptor 2 Does Not Contribute to Host Response during Postinfluenza Pneumococcal Pneumonia Am. J. Respir. Cell Mol. Biol., May 1, 2007; 36(5): 609 - 614. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Dessing, S. Knapp, S. Florquin, A. F. de Vos, and T. van der Poll CD14 Facilitates Invasive Respiratory Tract Infection by Streptococcus pneumoniae Am. J. Respir. Crit. Care Med., March 15, 2007; 175(6): 604 - 611. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jeyaseelan, S. K. Young, M. B. Fessler, Y. Liu, K. C. Malcolm, M. Yamamoto, S. Akira, and G. S. Worthen Toll/IL-1 Receptor Domain-Containing Adaptor Inducing IFN-beta (TRIF)-Mediated Signaling Contributes to Innate Immune Responses in the Lung during Escherichia coli Pneumonia J. Immunol., March 1, 2007; 178(5): 3153 - 3160. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Power, B. Li, M. Yamamoto, S. Akira, and T.-J. Lin A Role of Toll-IL-1 Receptor Domain-Containing Adaptor-Inducing IFN-beta in the Host Response to Pseudomonas aeruginosa Lung Infection in Mice J. Immunol., March 1, 2007; 178(5): 3170 - 3176. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Skerrett, C. B. Wilson, H. D. Liggitt, and A. M. Hajjar Redundant Toll-like receptor signaling in the pulmonary host response to Pseudomonas aeruginosa Am J Physiol Lung Cell Mol Physiol, January 1, 2007; 292(1): L312 - L322. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jeyaseelan, S. K. Young, M. Yamamoto, P. G. Arndt, S. Akira, J. K. Kolls, and G. S. Worthen Toll/IL-1R Domain-Containing Adaptor Protein (TIRAP) Is a Critical Mediator of Antibacterial Defense in the Lung against Klebsiella pneumoniae but Not Pseudomonas aeruginosa J. Immunol., July 1, 2006; 177(1): 538 - 547. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Plant, H. Wan, and A.-B. Jonsson MyD88-Dependent Signaling Affects the Development of Meningococcal Sepsis by Nonlipooligosaccharide Ligands. Infect. Immun., June 1, 2006; 74(6): 3538 - 3546. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |